Abstract
Introduction: Patients with human immunodeficiency virus (HIV) are at increased risk of developing malignancies linked to Kaposi's sarcoma-associated herpesvirus (KSHV), including Kaposi's sarcoma (KS). Notably, AIDS-associated Kaposi's sarcoma (AIDS-KS) has become more aggressive than other forms of KS, suggesting the existence of synergistic interaction between the products of KSHV and …